HomeEVOK • NASDAQ
add
Evoke Pharma Inc
Previous close
$4.41
Day range
$4.23 - $4.70
Year range
$3.55 - $12.32
Market cap
6.81M USD
Avg Volume
27.29K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 2.65M | 69.83% |
Operating expense | 3.84M | 22.50% |
Net income | -1.31M | 22.52% |
Net profit margin | -49.45 | 54.38% |
Earnings per share | -0.94 | 84.64% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 11.34M | 90.10% |
Total assets | 14.15M | 80.23% |
Total liabilities | 9.77M | 11.91% |
Total equity | 4.39M | — |
Shares outstanding | 2.07M | — |
Price to book | 1.48 | — |
Return on assets | -24.45% | — |
Return on capital | -37.70% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -1.31M | 22.52% |
Cash from operations | -818.70K | 21.40% |
Cash from investing | — | — |
Cash from financing | 2.98M | — |
Net change in cash | 2.16M | 307.49% |
Free cash flow | -196.21K | 64.62% |
About
Founded
2007
Headquarters
Website
Employees
4
